nir irradiation (Dojindo Labs)
Structured Review

Nir Irradiation, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 66879 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nir irradiation/product/Dojindo Labs
Average 99 stars, based on 66879 article reviews
Images
1) Product Images from "Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44–targeting antibody–photoabsorber conjugates"
Article Title: Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44–targeting antibody–photoabsorber conjugates
Journal: eBioMedicine
doi: 10.1016/j.ebiom.2025.105566
Figure Legend Snippet: Intratumoural delivery of CD44-IR700 enhanced efficacy of photoimmunotherapy in vivo . (a) Schematic of experimental schedule. Mice bearing subcutaneous Lewis lung carcinoma tumours were treated with either no CD44-IR700 (Ctrl), CD44-IR700 via IV injection (CD44-IR700_IV), or CD44-IR700 via IT injection (CD44-IR700_IT), followed by NIR light irradiation on subsequent days. (b) The ratio of tumour-infiltrating CD8-positive T cells in live cells, as determined by flow cytometry on day 7 post-treatment, from the CD44-IR700_IV and CD44-IR700_IT groups (n = 6 per group). (c) Immunohistochemical staining of tumours 7 days after photoimmunotherapy. CD8-positive T cells were stained. The scale bar represents 50 μm. The numbers of CD8-positive T cells per view field were counted (n = 5 mice for each group). (d) Cytokine expression in tumours, as determined by quantitative PCR analysis on day 3 post-treatment with photoimmunotherapy, from the CD44-IR700_IV and CD44-IR700_IT groups (n = 5 per group). (e) Tumour volume monitoring. Tumour size was measured starting from the day of CD44-IR700 administration (day 0), and the change in size was expressed as a ratio relative to the initial volume on day 0 (n = 12 per group). (f) Tumour volume ratio on day 7. The graph shows the fold increase in tumour volume on day 7 compared with that on day 0 (n = 12 per group). (g) Representative images displaying tumours from each treatment group on day 7 post-administration. (h) Representative images of tumours excised on day 7 post-treatment from each therapeutic group. Data are presented as mean + standard error of the mean. Statistical difference was assessed using Mann–Whitney U tests, with significance denoted by asterisks (∗ p < 0.05 and ∗∗∗∗ p < 0.0001). CD44-IR700, IR700-conjugated anti-CD44 monoclonal antibody; CD, cluster of differentiation; NIR, near-infrared; Ctrl, control; IV, intravenous; IT, intratumoural; Ifnγ, interferon-γ; and Tnf, tumour necrosis factor-alpha.
Techniques Used: In Vivo, IV Injection, Injection, Irradiation, Flow Cytometry, Immunohistochemical staining, Staining, Expressing, Real-time Polymerase Chain Reaction, MANN-WHITNEY, Control
Figure Legend Snippet: The interval between intratumoural administration of CD44-IR700 and NIR irradiation, whether 30 min or 24 h, yields the same effect . (a) Schematic of experimental schedule. Lewis Lung carcinoma cell-induced subcutaneous tumours were established in mice. The mice were divided into three groups for the following treatments: CD44-IR700_IV_24h: IV administration of CD44-IR700 and IT of PBS, with NIR light irradiation 24 h after administration; CD44-IR700_IT_24h: IT administration of CD44-IR700 and IV injection of PBS, followed by NIR light irradiation 24 h later; and CD44-IR700_IT_30m: IT administration of CD44-IR700 and IV injection of PBS, with NIR light irradiation conducted 30 min post-administration. (b) Tumour volume measurement. The tumour volume was monitored from the day of CD44-IR700 administration (designated as day 0), and the change in tumour size was presented as a ratio to the volume on the day of administration (n = 14–18 per group). (c) Tumour volume ratio on day 7 relative to day 0 (n = 14–18 per group). Data are expressed as mean + standard error of the mean. Statistical difference was assessed using Kruskal–Wallis test, with asterisks denoting the levels of significance (∗ p < 0.05). ‘ns’ indicates a lack of statistical significance. CD44-IR700, IR700-conjugated anti-CD44 monoclonal antibody; PBS, phosphate-buffered saline; CD, cluster of differentiation; NIR, near-infrared; Ctrl, control; IV, intravenous; and IT, intratumoural.
Techniques Used: Irradiation, IV Injection, Saline, Control


